UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045093
Receipt number R000051514
Scientific Title The level of skin injury depending on the way to remove medical film dressings: quantification of detached corneocytes
Date of disclosure of the study information 2021/08/10
Last modified on 2021/08/08 12:35:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The level of skin injury depending on the way to remove medical film dressings

Acronym

Skin injury during removal of film dressings

Scientific Title

The level of skin injury depending on the way to remove medical film dressings: quantification of detached corneocytes

Scientific Title:Acronym

quantification of detached corneocytes during removal of film dressings

Region

Japan


Condition

Condition

targeting healthy volunteers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The extent to which the epidermal keratin is damaged by the method of removing the medical film with a disinfectant will be compared and examined by the peeling angle mass for healthy subjects, and the peeling method that minimizes the damage of the keratin damage will be examined.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Amount of total protein extracted from corneocytes attached to removed film dressings is compared depending on the ways of removal.

Key secondary outcomes

Profilaggrin level can be a target molecule reflecting detached immature corneocytes.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Medical film dressings in a same size are attached to bilateral forearms of healthy volunteers. Thirty minutes later, the films are removed in different ways. Proteins of attached corneocytes to the films are extracted and quantified with the BCA assay.Intervention every 2 weeks for a total of 6 weeks

Interventions/Control_2

The procedures described above are performed on forearms with or without a single application of a topical moisturizer.

Interventions/Control_3

The procedures described in intervention 1 and 2 are performed using medical film dressings containing iodine.
There are four groups of intervention groups: differences in medical film peeling methods and moisturizer interventions, and differences in disinfectant film peeling methods and moisturizer interventions.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Healthy medical professionals at the
Facility to which the principal investigator belongs who wish to participate

Key exclusion criteria

Those who are allergic to disinfectans

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Ranko
Middle name
Last name Hinooka

Organization

Asahikawa Medical University Hospital

Division name

Nursing Department

Zip code

078-8510

Address

Asahikawa City Midorigaoka Higashi 2-1

TEL

0166693604

Email

hinooka@asahikawa-med.ac.jp


Public contact

Name of contact person

1st name Ranko
Middle name
Last name Hinooka

Organization

Asahikawa Medical University Hospital

Division name

Nursing Department

Zip code

078-8510

Address

Asahikawa City Midorigaoka Higashi 2- 1

TEL

0166693604

Homepage URL


Email

hinooka@asahikawa-med.ac.jp


Sponsor or person

Institute

Ministry of education

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

none

Name of secondary funder(s)

none


IRB Contact (For public release)

Organization

Asahikawa Medical University Hospital

Address

Asahikawa City Midorigaoka Higashi 2-1

Tel

0166693604

Email

hinooka@asahikawa-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

旭川医科大学病院


Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 08 Month 10 Day

Date of IRB


Anticipated trial start date

2021 Year 08 Month 20 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 08 Month 08 Day

Last modified on

2021 Year 08 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051514